Monday, April 28, 2025

Latest

Cronos Confirms That It Has Received Expressions Of Interest, While Curaleaf Refuses To Comment

Cronos Group (TSX: CRON) has confirmed that it has received what amounts to “a number” of unsolicited indications of interest for the potential sale of the company.

The indications of interest are said to come from third parties, with each involving a potential transaction. Cronos however has not provided details on who is seemingly interested in acquiring the company, instead electing to state that it is in the early stages of reviewing each offer, and that there can be no assurance that anything comes of the discussions.

The announcement follows a rumor that was leaked and reported on by Reuters, who suggested that the Canadian cannabis operator was in discussions to be acquired by Curaleaf Holdings (CSE: CURA), a US-based multi-state operator.

Curaleaf for its part at the request of IIROC this morning commented on the media reports, just to say that the company’s policy is “to refrain from commenting on market rumors.”

The confirmation of third party expressions of interest being received by Cronos all but confirms that the “leak” was conducted in an attempt to get a higher figure in a potential sale. That strategy however has appeared to fail spectacularly, with Cronos closing down 3%, after initially jumping over 19%.


Information for this briefing was found via Sedar, Reuters and the sources mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Leave a Reply

Video Articles

Bell Q3 Earnings: Massive Impairments. Guidance Cuts. A Mess.

Alamos Gold Q3: Record Revenue & Production Amid Rising Costs

The Junior Mining Market Is Back

Recommended

Germany Looks To Modernize Military Recruitment But Stops Short of Conscription

First Majestic Silver Posts Topline Revenue Of $146.1 Million In Q3 2024

Related News

Curaleaf Holdings Sees Revenues Climb 55% To $182.4 Million, Announces CEO Transition

Curaleaf Holdings (CSE: CURA) this evening reported its third quarter financial results, reporting total revenue...

Tuesday, November 17, 2020, 04:39:50 PM

Cronos Group: Raymond James Sees US$4.10/Share Valuation Just For Ginkgos Partnership

Raymond James recently upgraded Cronos Group (TSX: CRON) (NASDAQ: CRON) to an Outperform 2 rating...

Friday, July 3, 2020, 01:52:39 PM

Curaleaf Q1 2023 Financials: Higher Revenue, Lower Margins, Wider Losses

Curaleaf Holdings (CSE: CURA) reported its Q1 2023 financials late last night, just days after...

Thursday, May 18, 2023, 08:57:18 AM

SEC Charges Cronos Group With Accounting Fraud

Canadian cannabis company Cronos Group Inc (TSX: CRON) and its former senior executive were charged...

Monday, October 24, 2022, 05:52:17 PM

Cronos Group: Canaccord Lifts Rating, Price Target On Q1 Earnings Beat

On May 10, Cronos Group (TSX: CRON) reported its first quarter financial results. The company...

Friday, May 13, 2022, 04:37:00 PM